Nancy Backus
Internal Medicine · Savannah, GANPI 1730325085
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.3% of the total across 2 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Braeburn Inc. accounts for 95.3% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for internal medicine clinicians in GA, where the typical reported total is $311.
Across 2 payments — averaging $8.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Braeburn Inc.$16
- Sumitomo Pharma America, Inc.$1
Across 57 payments — averaging $21,397 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$432K
- Mylan Technologies Inc.$422K
- Pfizer$174K
- Teva Pharmaceuticals USA, Inc.$122K
- Sage Therapeutics, LLC$59K
- Alnylam Pharmaceuticals Inc.$10K
- plus $84 from 1 others
What the payments were for
- Food & beverage$1695%
- Education$15%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Braeburn Inc. | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $1 |
How this compares
$17 in reported general payments places this provider in the 10th percentile of 3,311 internal medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 37 | $43,081 |
| OzempicSemaglutide | 26 | $34,449 |
| JardianceEmpagliflozin | 11 | $20,046 |
| FarxigaDapagliflozin Propanediol | 11 | $13,432 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 15 | $9,611 |
| LinzessLinaclotide | 14 | $8,423 |
| Nifedipine ErNifedipine | 52 | $1,742 |
| SynthroidLevothyroxine Sodium | 16 | $1,356 |
| Rosuvastatin Calcium | 97 | $1,211 |
| Levothyroxine Sodium | 47 | $994 |
| Duloxetine Hcl | 40 | $796 |
| Morphine Sulfate ErMorphine Sulfate | 35 | $561 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $433 |
| Losartan Potassium | 33 | $404 |
| Tamsulosin Hcl | 12 | $340 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Savannah
- Jennifer WoehlerSavannah$207K
- Timothy ConnellySavannah$50K
- John DemiccoSavannah$31K
- Paul BradleySavannah$28K
- Wilfredo DolorSavannah$17K
- Thomas HoganSavannah$17K
- Thomas MoriaritySavannah$16K
- Michael GibsonSmyrna$2.2M
- Eduard FatakhovAlpharetta$376K
- Tracey HenryAtlanta$305K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.